The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning
© 2020 National Academy of Sciences. All rights reserved. Small molecules can affect many cellular processes. The disambiguation of these effects to identify the causative mechanisms of cell death is extremely challenging. This challenge impacts both clinical development and the interpretation of ch...
Main Authors: | Bruno, Peter M, Lu, Mengrou, Dennis, Kady A, Inam, Haider, Moore, Connor J, Sheehe, John, Elledge, Stephen J, Hemann, Michael T, Pritchard, Justin R |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
Proceedings of the National Academy of Sciences
2021
|
Online Access: | https://hdl.handle.net/1721.1/136236 |
Similar Items
-
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma
by: Min Pan, et al.
Published: (2021-11-01) -
CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer
by: Robert Cornelison, et al.
Published: (2021-10-01) -
Effects of the G-quadruplex-binding drugs quarfloxin and CX-5461 on the malaria parasite Plasmodium falciparum
by: Holly M. Craven, et al.
Published: (2023-12-01) -
CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer
by: Jiachen Xuan, et al.
Published: (2020-11-01) -
Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461
by: Guihong Li, et al.
Published: (2018-04-01)